1. Home
  2. ASST vs SKYE Comparison

ASST vs SKYE Comparison

Compare ASST & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASST
  • SKYE
  • Stock Information
  • Founded
  • ASST 2020
  • SKYE 2012
  • Country
  • ASST United States
  • SKYE United States
  • Employees
  • ASST N/A
  • SKYE N/A
  • Industry
  • ASST Computer Software: Prepackaged Software
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASST Technology
  • SKYE Health Care
  • Exchange
  • ASST Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • ASST 111.2M
  • SKYE 108.5M
  • IPO Year
  • ASST 2023
  • SKYE N/A
  • Fundamental
  • Price
  • ASST $3.68
  • SKYE $3.91
  • Analyst Decision
  • ASST
  • SKYE Buy
  • Analyst Count
  • ASST 0
  • SKYE 7
  • Target Price
  • ASST N/A
  • SKYE $15.50
  • AVG Volume (30 Days)
  • ASST 9.7M
  • SKYE 314.0K
  • Earning Date
  • ASST 11-13-2025
  • SKYE 11-06-2025
  • Dividend Yield
  • ASST N/A
  • SKYE N/A
  • EPS Growth
  • ASST N/A
  • SKYE N/A
  • EPS
  • ASST N/A
  • SKYE N/A
  • Revenue
  • ASST N/A
  • SKYE N/A
  • Revenue This Year
  • ASST N/A
  • SKYE N/A
  • Revenue Next Year
  • ASST N/A
  • SKYE N/A
  • P/E Ratio
  • ASST N/A
  • SKYE N/A
  • Revenue Growth
  • ASST 111.73
  • SKYE N/A
  • 52 Week Low
  • ASST $0.34
  • SKYE $1.14
  • 52 Week High
  • ASST $13.42
  • SKYE $6.01
  • Technical
  • Relative Strength Index (RSI)
  • ASST 40.74
  • SKYE 54.00
  • Support Level
  • ASST $7.51
  • SKYE $3.71
  • Resistance Level
  • ASST $12.60
  • SKYE $4.55
  • Average True Range (ATR)
  • ASST 1.55
  • SKYE 0.31
  • MACD
  • ASST -0.22
  • SKYE 0.02
  • Stochastic Oscillator
  • ASST 0.45
  • SKYE 49.61

About ASST Asset Entities Inc. Class B

Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. The company has developed three categories of services, which include: providing subscription upgrades to premium content on investment education and entertainment servers on Discord; co-developing and executing influencer social media and marketing campaigns for clients; and designing, developing, and managing Discord servers for clients under AE.360.DDM brand. In addition, it offers Ternary v2, a cloud-based subscription management and payment processing solution for Discord communities, which includes a suite of customer relations management tools and Stripe-verified payment processing.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: